Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-21 Sale |
2025-01-23 9:19 pm |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer |
33,266 | $1.702 | $56,620 | 231,744 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 5:18 pm |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph Chief Executive Officer |
12,619 | $1.593 | $20,102 | 667,488 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 5:16 pm |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec |
3,418 | $1.59 | $5,435 | 161,127 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 5:14 pm |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
2,914 | $1.6102 | $4,692 | 136,117 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 5:06 pm |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
3,219 | $1.59 | $5,118 | 170,298 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 8:09 pm |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph Chief Executive Officer |
47,778 | $1.8392 | $87,873 | 1,018,107 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 7:57 pm |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec |
11,122 | $1.8437 | $20,506 | 264,845 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 7:55 pm |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
7,636 | $1.8629 | $14,225 | 213,731 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 7:53 pm |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer |
13,235 | $1.8411 | $24,367 | 365,310 (Direct) |
View |
| 2025-01-03 Sale |
2025-01-07 7:48 pm |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
10,859 | $1.8461 | $20,047 | 273,817 (Direct) |
View |
| 2024-01-19 Sale |
2024-01-19 7:07 pm |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
15,200 | $3.4706 | $52,753 | 502,485 (Direct) |
View |
| 2024-01-19 Sale |
2024-01-19 7:06 pm |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec |
8,933 | $3.4757 | $31,048 | 108,867 (Direct) |
View |
| 2024-01-18 Sale |
2024-01-19 7:05 pm |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer |
4,242 | $3.705 | $15,717 | 211,445 (Direct) |
View |
| 2024-01-18 Sale |
2024-01-19 7:05 pm |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
3,124 | $3.7144 | $11,604 | 117,576 (Direct) |
View |
| 2024-01-18 Sale |
2024-01-19 7:04 pm |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
2,833 | $3.7258 | $10,555 | 96,867 (Direct) |
View |
| 2023-08-17 Sale |
2023-08-18 6:31 pm |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
41,949 | $6.492 | $272,334 | 0 (Direct) |
View |
| 2023-07-21 Purchase |
2023-07-25 4:30 pm |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
5,161,290 | $7.75 | $39,999,998 | 14,932,063 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-07 Option Award |
2025-01-07 8:09 pm |
N/A 2035-01-07 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph Chief Executive Officer |
563,400 | $0 | 1,018,107 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 8:02 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Schacterle Amy Chief Regulatory Officer |
22,000 | $0 | 22,000 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 8:00 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Doherty James J. President and CDO |
155,900 | $0 | 155,900 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 7:57 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec |
167,100 | $0 | 264,845 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 7:55 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
124,500 | $0 | 213,731 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 7:53 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer |
167,100 | $0 | 365,310 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 7:48 pm |
N/A 2035-01-06 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
167,100 | $0 | 273,817 (Direct) |
View |
| 2024-11-05 Option Award |
2024-11-06 5:27 pm |
N/A 2034-11-05 |
Acumen Pharmaceuticals Inc. | ABOS | Schacterle Amy Chief Regulatory Officer |
340,000 | $0 | 340,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 5:26 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:54 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:51 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:49 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:46 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Porter Derrell Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:41 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-10 4:40 pm |
N/A 2034-06-09 |
Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-01 5:02 pm |
N/A 2034-02-01 |
Acumen Pharmaceuticals Inc. | ABOS | Doherty James J. President and CDO |
601,000 | $0 | 601,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:23 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
183,000 | $0 | 209,700 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:22 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | Meisner Derek M Chief Legal Officer & Corp Sec |
228,000 | $0 | 254,800 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:21 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
235,000 | $0 | 261,700 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:20 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt CFO & Chief Business Officer |
265,000 | $0 | 374,687 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:18 pm |
N/A 2034-01-01 |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
1,003,000 | $0 | 1,119,685 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-18 6:31 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
39,149 | $0.72 | 0 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-18 6:31 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
2,800 | $1.19 | 0 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-18 6:31 pm |
N/A 2029-03-01 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
41,949 | $0 | 0 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-13 4:21 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
25,000 | $0 | 25,000 (Indirect) |
View |
| 2023-06-06 Option Award |
2023-06-07 5:45 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 5:44 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 5:43 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Porter Derrell Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 5:43 pm |
N/A 2033-06-05 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
25,000 | $0 | 25,000 (Direct) |
View |